Osteocraniostenosis
Description
Osteocraniostenosis is a lethal skeletal dysplasia characterized by a cloverleaf skull anomaly, facial dysmorphism, limb shortness, splenic hypo/aplasia and radiological anomalies including thin tubular bones with flared metaphyses and deficient calvarial mineralization.
Clinical Features
Top most frequent phenotypes and symptoms related to Osteocraniostenosis
- Seizures
- Global developmental delay
- Short stature
- Generalized hypotonia
- Microcephaly
- Growth delay
- Hypertelorism
- Failure to thrive
- Abnormal facial shape
- Cleft palate
And another 55 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Osteocraniostenosis Is also known as habrodysplasia, osteocraniostenosis, gracile bone dysplasia, skeletal dysplasia, lethal, with gracile bones, osteocraniosplenic syndrome.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Osteocraniostenosis Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Hypoparathyroidism Deletion/Duplication Panel.
By Genetic Services Laboratory University of Chicago (United States).
STX16, TBCE, TBX1, CASR, CHD7, FAM111A, CYP24A1, AIRE, GATA3, GCM2, GNA11, GNAS, HADHA, HADHB, PDE4D, PRKAR1A, PTH
Specificity
6 %
Genes
100 % |
Hypoparathyroidism sequencing panel.
By Genetic Services Laboratory University of Chicago (United States).
STX16, TBCE, TBX1, CASR, CDH7, FAM111A, CYP24A1, AIRE, GATA3, GCM2, GNA11, GNAS, HADHA, HADHB, PDE4D, PRKAR1A, PTH
Specificity
6 %
Genes
100 % |
Kenny-Caffey syndrome, type 2 (KCS2, sequence analysis of FAM111A gene).
By CGC Genetics (Portugal).
FAM111A
Specificity
100 %
Genes
100 % |
Hypomagnesemia (NGS panel for 17 genes).
By CGC Genetics (Portugal).
CNNM2, SLC12A3, HNF1B, CASR, BSND, SARS2, TRPM6, CLCNKB, CLDN16, CLDN19, FAM111A, EGF, EGFR, FXYD2, KCNA1, KCNJ10, PCBD1
Specificity
6 %
Genes
100 % |
Hypomagnesemia (NGS panel for 17 genes).
By CGC Genetics (Portugal).
CNNM2, SLC12A3, HNF1B, CASR, BSND, SARS2, TRPM6, CLCNKB, CLDN16, CLDN19, FAM111A, EGF, EGFR, FXYD2, KCNA1, KCNJ10, PCBD1
Specificity
6 %
Genes
100 % |
Kenny-Caffey Syndrome Sequencing Panel with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
TBCE, FAM111A
Specificity
50 %
Genes
100 % |
Hypoparathyroidism Sequencing Panel with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
SOX3, STX16, TBCE, CASR, FAM111A, AIRE, GATA3, GCM2, GNA11, GNAS, HADHA, HADHB, AP2S1, PTH, PTH1R
Specificity
7 %
Genes
100 % |
Hypomagnesemia Sequencing Panel with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
CNNM2, SLC12A3, HNF1B, CASR, BSND, SARS2, TRPM6, CLDN16, CLDN19, FAM111A, EGF, EGFR, FXYD2, KCNA1, KCNJ10, PCBD1
Specificity
7 %
Genes
100 % |
You can get up to 13 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM MESH ORPHANET Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME; SSMS GELEOPHYSIC DYSPLASIA 1; GPHYSD1 LIMITED CUTANEOUS SYSTEMIC SCLEROSIS HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2; HNFJ2